2023
Using micro-cognition biomarkers of neurosystem dysfunction to redefine ADHD subtypes: A scalable digital path to diagnosis based on brain function
Wexler B, Kish R. Using micro-cognition biomarkers of neurosystem dysfunction to redefine ADHD subtypes: A scalable digital path to diagnosis based on brain function. Psychiatry Research 2023, 326: 115348. PMID: 37494880, PMCID: PMC10517859, DOI: 10.1016/j.psychres.2023.115348.Peer-Reviewed Original ResearchConceptsPoor response inhibitionResponse inhibitionSymptom-based diagnosisGO/NOGO testMarked performance decrementsNew treatment developmentTD childrenADHD childrenADHD subtypesPerformance decrementsInconsistent attentionAbstract categoriesTreatment developmentNatural categoriesBrain functionADHDDifferent neuropathologiesChildren 6Individual patientsTreatment selection
1991
Failure at task-specific regional brain activation: new conceptualization of a disease entity
Wexler B. Failure at task-specific regional brain activation: new conceptualization of a disease entity. Journal Of Neuropsychiatry 1991, 3: 94-98. PMID: 7580183, DOI: 10.1176/jnp.3.1.94.Peer-Reviewed Original ResearchConceptsNormal brain functionSymptom-based diagnosisRegional brain activationBrain functionBrain activationGroup of patientsCurrent symptom-based diagnosesMultiple brain regionsSpecific anatomic locationsClinical courseEtiologic diagnosisDisease entityAnatomic locationClinical practiceCurrent diagnostic systemsNew treatmentsPathophysiological processesBrain regionsDSM-IIIOrgan systemsDiagnosisBranches of medicinePhysiological dysfunctionNormal functionPatients